Medicine and Dentistry
Brain Ischemia
66%
Meta-Analysis
33%
Parkinson's Disease
33%
Cerebral Hemorrhage
25%
Systematic Review
22%
Percutaneous Thrombectomy
22%
Randomized Controlled Trial
13%
Nasopharynx Carcinoma
11%
Chemoradiotherapy
11%
Head and Neck Squamous Cell Carcinoma
11%
UFT
11%
Myocardial Infarction
11%
Immune Response
11%
Acetylcholinesterase Inhibitor
11%
STAT3 Protein
11%
Disease Assessment
11%
Drug-Eluting Stent
11%
Basilar Artery
11%
Combination Therapy
11%
Disability
11%
Artery Occlusion
11%
Ipilimumab
11%
Anticoagulant
11%
Nivolumab
11%
Myasthenia gravis
11%
Myositis
11%
Polyneuropathy
11%
Non Small Cell Lung Cancer
11%
Degenerative Disease
11%
Alzheimer's Disease
11%
Glucagon-Like Peptide-1 Agonist
11%
Predictive Modeling
11%
Apoplexy
10%
National Institutes of Health Stroke Scale
8%
Symptom
8%
Antithrombotic
7%
Survival Rate
7%
Overall Survival
7%
Immune-Related Adverse Events
7%
Muscle Weakness
7%
Electromyography
7%
Dyspnea
7%
Diabetes
6%
Clinical Trial
6%
Antidiabetic Agent
6%
Blood Clot Lysis
5%
Programmed Death-Ligand 1
5%
Modified Rankin Scale
5%
Vitamin K Antagonist
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
55%
Brain Ischemia
47%
Randomized Controlled Trial
26%
Alzheimer's Disease
22%
Clinical Trial
17%
Symptom
15%
Heart Infarction
11%
Nasopharynx Carcinoma
11%
Cholinesterase Inhibitor
11%
Chemoradiation Therapy
11%
Disability
11%
Brain Derived Neurotrophic Factor
11%
UFT
11%
STAT3 Protein
11%
Probiotic Agent
11%
Artery Occlusion
11%
Combination Therapy
11%
Head and Neck Squamous Cell Carcinoma
11%
Acetylsalicylic Acid
11%
Clopidogrel
11%
Folic Acid
11%
Transient Ischemic Attack
11%
Vitamin B12
11%
Cilostazol
11%
Degenerative Disease
11%
Glucagon Like Peptide 1 Receptor Agonist
11%
Brain Hemorrhage
8%
Overall Survival
7%
Survival Rate
7%
Antidiabetic Agent
6%
Rankin Scale
5%
Neuroscience
Parkinson's Disease
100%
Cognitive Disorders
22%
Motor Skills
22%
Neurofilament Light Chain
22%
Brain Ischemia
22%
Meta-Analysis
22%
Alzheimer's Disease
21%
Cognitive Function
17%
Mild Cognitive Impairment
13%
Artificial Neural Network
12%
Depression
11%
Randomized Controlled Trial
11%
Brain-Derived Neurotrophic Factor
11%
Brain Age
11%
Amyloid
11%
Monoamine Oxidase B
11%
Acetylcholinesterase Inhibitor
11%
Cyanocobalamin
11%
Folic Acid
11%
Treatment of Alzheimer's Disease
11%
Glucagon-Like Peptide-1 Agonist
11%
Neurodegenerative Disorder
11%
Cerebrovascular Accident
11%